Prior Authorization: A Growing Hurdle for Rare Disease Patients

Prior Authorization: A Growing Hurdle for Rare Disease Patients

For individuals and families navigating the complexities of inherited retinal diseases (IRDs), access to timely and effective treatments is paramount. However, a common health insurance practice known as prior authorization (PA) is increasingly posing significant challenges, potentially delaying care and impacting patient outcomes. This issue is particularly critical for the rare disease community, where treatment options may be limited or considered